Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
Sara Lega, Samuele Naviglio, Stefano Volpi, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 224-224
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
Abdolreza Esmaeilzadeh, Reza Elahi
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2519-2543
Open Access | Times Cited: 89
SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney
Magen E. Francis, Una Goncin, Andrea Kroeker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009705-e1009705
Open Access | Times Cited: 83
Aprotinin Inhibits SARS-CoV-2 Replication
Denisa Bojková, Marco Bechtel, Katie-May McLaughlin, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2377-2377
Open Access | Times Cited: 82
PATHOLOGICAL ANATOMY OF INFECTION CAUSED BY SARS-COV-2
Е А Коган, Yu.S. Berezovsky, Д. Д. Проценко, et al.
Russian Journal of Forensic Medicine (2020) Vol. 6, Iss. 2, pp. 8-30
Open Access | Times Cited: 77
Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection
Terry Zhou, Nora J. Gilliam, Sizhen Li, et al.
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 26
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
Roberto Gozalbo‐Rovira, Estela Giménez, Víctor Latorre, et al.
Journal of Clinical Virology (2020) Vol. 131, pp. 104611-104611
Open Access | Times Cited: 69
The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections
Alexander Panossian, Thomas Brendler
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 236-236
Open Access | Times Cited: 53
Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury
Lúcio Ricardo Leite Diniz, Marília Trindade de Santana Souza, Allana Brunna Sucupira Duarte, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5772-5772
Open Access | Times Cited: 41
Pathology of Red Blood Cells in Patients with SARS-CoV-2
Sona Hakobyan, Lina Hakobyan, Liana Abroyan, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 191-191
Open Access
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Deciphering SARS-CoV-2 Virologic and Immunologic Features
Grégorie Lebeau, Damien Vagner, Étienne Frumence, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5932-5932
Open Access | Times Cited: 38
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 479-503
Closed Access | Times Cited: 36
COVID-19: The Immune Responses and Clinical Therapy Candidates
Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5559-5559
Open Access | Times Cited: 33
Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
Lara Herrera, Myriam Martin‐Inaraja, Silvia J. Santos, et al.
Immunology (2021) Vol. 165, Iss. 2, pp. 234-249
Open Access | Times Cited: 29
Potential Nutraceuticals for COVID-19
Sayali Savant, Shraddha Srinivasan, Anil Kumar Kruthiventi
Nutrition and Dietary Supplements (2021) Vol. Volume 13, pp. 25-51
Open Access | Times Cited: 27
Edible and Herbal Plants for the Prevention and Management of COVID-19
Sha Li, Chien‐shan Cheng, Cheng Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
The role of HMGB1 in COVID‐19‐induced cytokine storm and its potential therapeutic targets: A review
Sri Wulandari, Hartono Hartono, Tri Wibawa
Immunology (2022) Vol. 169, Iss. 2, pp. 117-131
Open Access | Times Cited: 19
Cell‐mediated immunity to SARS‐CoV‐2
Xiaolin Wang, Jingang Gui
Pediatric Investigation (2020) Vol. 4, Iss. 4, pp. 281-291
Open Access | Times Cited: 29
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
Marco Caminati, Gabriella Guarnieri, Gianenrico Senna
Vaccines (2021) Vol. 9, Iss. 1, pp. 38-38
Open Access | Times Cited: 23
Critical review on Rumex dentatus L. a strong pharmacophore and the future medicine: Pharmacology, phytochemical analysis and traditional uses
Tahirah Khaliq, Sabiyah Akhter, Phalisteen Sultan, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14159-e14159
Open Access | Times Cited: 10
SARS-CoV-2 Nucleocapsid protein is decorated with multiple N- and O-glycans
Nitin T. Supekar, Asif Shajahan, Anne Gleinich, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 24
Coronavirus infection: An immunologists' perspective
Juan Bautista De Sanctis, Alexis García, Dolores Moreno, et al.
Scandinavian Journal of Immunology (2021) Vol. 93, Iss. 6
Open Access | Times Cited: 22
Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19
Francesco Pinotti, Paul S. Wikramaratna, Uri Obolski, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 20
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
Narasimha M. Beeraka, SubbaRao V. Tulimilli, Medha Karnik, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 20
The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro
Katja Merches, Leonie Breunig, Julia Fender, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2341-2360
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top